EBOS GROUP LIMITED — Capital/Financing Update 2017

Oct 24, 2017

==> picture [176 x 53] intentionally omitted <==

24 October 2017

NZX/ASX Code: EBO

EBOS acquires cornerstone shareholding in MedAdvisor

EBOS is pleased to announce that it has made an investment of A$10.5 million to acquire a strategic 14.1% shareholding in Australia’s leading digital medication management company, MedAdvisor Limited (ASX: MDR).

MedAdvisor’s software system has wide customer acceptance with over 900,000 users and is connected to over 2,600 Australian pharmacies.

EBOS' investment is part of a wider partnership with MedAdvisor that will seek to advance the commercial interests of both organisations by increasing the availability of digital health applications across EBOS' community pharmacy and institutional healthcare businesses.

For further information, please contact:

Mark Connell Group Investor Relations Manager EBOS Group Limited +61 402 995 519

About EBOS Group

EBOS Group Limited (NZX/ASX Code: EBO) is the largest and most diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It is also a leading Australasian animal care products marketer and distributor.

EBOS Group Limited. NZBN 9429031998840

Level 7, 737 Bourke Street, Docklands, Victoria 3008, Australia. PO Box 7300, Melbourne, Victoria 8004, Australia. Phone: +61 3 9918 5555, Fax: +61 3 9918 5588.

1

www.ebosgroup.com